The FLAURA Trial: Practice-Changing Results for Patients with EGFR Mutation-Positive NSCLC (BMIC-007)

Dr. Jack West summarizes the likely practice-changing results of the FLAURA trial of osimertinib vs. standard of care EGFR TKI therapy (gefitinib or erlotinib) as first line treatment for patients wit... Author: BeaconMedIC Added: 09/10/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts